磷酸化原癌基因c-kit抗體 返回列表頁(yè)

英文名稱(chēng) Phospho-c-Kit(Tyr703)
中文名稱(chēng) 磷酸化原癌基因c-kit抗體
別    名 c-Kit (phospho Y703); c-Kit (phospho Tyr703); p-c-Kit (Tyr 703); C Kit; c-Kit; CD 117; CD117; CD117 antigen; KIT; KIT_HUMAN; Mast/stem cell growth factor receptor; Mast/stem cell growth factor receptor Kit; p145 c-kit; PBT; Piebald trait protein; Proto oncogene c Kit; Proto oncogene tyrosine protein kinase Kit; Proto-oncogene c-Kit; SCF Receptor; SCFR; soluble KIT variant 1; Stem cell factor receptor; tyrosine protein kinase Kit; Tyrosine-protein kinase Kit; v kit Hardy Zuckerman 4 feline sarcoma viral oncogene homolog; v kit Hardy Zuckerman 4 feline sarcoma viral oncogene like protein; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog.
 磷酸化原癌基因c-kit抗體 
說(shuō) 明 書(shū) 0.1ml  
產(chǎn)品類(lèi)型 磷酸化抗體 
研究領(lǐng)域 腫瘤  信號(hào)轉(zhuǎn)導(dǎo)  轉(zhuǎn)錄調(diào)節(jié)因子  激酶和磷酸酶  細(xì)胞膜受體  
抗體來(lái)源 Rabbit
克隆類(lèi)型 Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse, 
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 145kDa
細(xì)胞定位 細(xì)胞漿 細(xì)胞膜 
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human c-Kit around the phosphorylation site of Tyr703
亞    型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
 產(chǎn)品介紹 background:
c-Kit is a transmembrane tyrosine kinase encoded by the cKit proto oncogene. c-Kit acts to regulate a variety of biological responses including cell proliferation, apoptosis, chemotaxis and adhesion. Ligand binding to the extracellular domain leads to autophosphorylation on several tyrosine residues within the cytoplasmic domain, and activation. Mutations in c-Kit have been found to be important for tumor growth and progression in a variety of cancers including mast cell diseases, gastrointestinal stromal tumor, acute myeloid leukemia, Ewing sarcoma and lung cancer. Phosphorylation at tyrosine 721 of c-Kit allows binding and activation of PI3 kinase.

Function:
Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine KITLG/SCF and plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. In response to KITLG/SCF binding, KIT can activate several signaling pathways. Phosphorylates PIK3R1, PLCG1, SH2B2/APS and CBL. Activates the AKT1 signaling pathway by phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Activated KIT also transmits signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3, STAT5A and STAT5B. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate.

Subunit:
Monomer in the absence of bound KITLG/SCF. Homodimer in the presence of bound KITLG/SCF, forming a heterotetramer with two KITLG/SCF molecules. Interacts (via phosphorylated tyrosine residues) with the adapter proteins GRB2 and GRB7 (via SH2 domain), and SH2B2/APS. Interacts (via C-terminus) with MPDZ (via the tenth PDZ domain). Interacts (via phosphorylated tyrosine residues) with PIK3R1 and PIK3 catalytic subunit. Interacts (via phosphorylated tyrosine) with CRK (isoform Crk-II), FYN, SHC1 and MATK/CHK (via SH2 domain). Interacts with LYN and FES/FPS. Interacts (via phosphorylated tyrosine residues) with the protein phosphatases PTPN6/SHP-1 (via SH2 domain), PTPN11/SHP-2 (via SH2 domain) and PTPRU. Interacts with PLCG1. Interacts with DOK1 and TEC. Subcellular Location : Isoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2: Cell membrane; Single-pass type I membrane protein. Isoform 3: Cytoplasm. Note=Detected in the cytoplasm of spermatozoa, especially in the equatorial and subacrosomal region of the sperm head.

Subcellular Location:
Isoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2: Cell membrane; Single-pass type I membrane protein. Isoform 3: Cytoplasm. Note=Detected in the cytoplasm of spermatozoa, especially in the equatorial and subacrosomal region of the sperm head.

Tissue Specificity:
Isoform 1 and isoform 2 are detected in spermatogonia and Leydig cells. Isoform 3 is detected in round spermatids, elongating spermatids and spermatozoa (at protein level). Widely expressed. Detected in the hematopoietic system, the gastrointestinal system, in melanocytes and in germ cells.

Post-translational modifications:
Ubiquitinated by SOCS6. KIT is rapidly ubiquitinated after autophosphorylation induced by KITLG/SCF binding, leading to internalization and degradation.
Autophosphorylated on tyrosine residues. KITLG/SCF binding enhances autophosphorylation. Isoform 1 shows low levels of tyrosine phosphorylation in the absence of added KITLG/SCF (in vitro). Kinase activity is down-regulated by phosphorylation on serine residues by protein kinase C family members. Phosphorylation at Tyr-568 is required for interaction with PTPN11/SHP-2, CRK (isoform Crk-II) and members of the SRC tyrosine-protein kinase family. Phosphorylation at Tyr-570 is required for interaction with PTPN6/SHP-1. Phosphorylation at Tyr-703, Tyr-823 and Tyr-936 is important for interaction with GRB2. Phosphorylation at Tyr-721 is important for interaction with PIK3R1. Phosphorylation at Tyr-823 and Tyr-936 is important for interaction with GRB7.

DISEASE:
Defects in KIT are a cause of piebald trait (PBT) [MIM:172800]. PBT is an autosomal dominant genetic developmental abnormality of pigmentation characterized by congenital patches of white skin and hair that lack melanocytes.
Defects in KIT are a cause of gastrointestinal stromal tumor (GIST) [MIM:606764].
Defects in KIT have been associated with testicular germ cell tumor (TGCT) [MIM:273300]. A common solid malignancy in males. Germ cell tumors of the testis constitute 95% of all testicular neoplasms.
Defects in KIT are a cause of acute myelogenous leukemia (AML) [MIM:601626]. AML is a malignant disease in which hematopoietic precursors are arrested in an early stage of development. Note=Somatic mutations that lead to constitutive activation of KIT are detected in AML patients. These mutations fall into two classes, the most common being in-frame internal tandem duplications of variable length in the juxtamembrane region that disrupt the normal regulation of the kinase activity. Likewise, point mutations in the kinase domain can result in a constitutively activated kinase.

Similarity:
Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
Contains 5 Ig-like C2-type (immunoglobulin-like) domains.
Contains 1 protein kinase domain.

Gene ID:
3815

Database links:

Entrez Gene: 3815 Human

Entrez Gene: 16590 Mouse

Entrez Gene: 64030 Rat

Omim: 164920 Human

SwissProt: P10721 Human

SwissProt: P05532 Mouse

Unigene: 479754 Human

Unigene: 247073 Mouse

Unigene: 54004 Rat

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

 xy-9839R C17ORF3917號(hào)染色體開(kāi)放閱讀框39抗體
xy-8524R Calcium Sensing Receptor鈣敏感受體1抗體
xy-4902R Calponin 1 + 2 + 3鈣結(jié)合蛋白Calponin抗體
xy-9814R C2orf442號(hào)染色體開(kāi)放閱讀框44抗體
xy-9817R C2orf552號(hào)染色體開(kāi)放閱讀框55抗體
xy-9818R C2orf572號(hào)染色體開(kāi)放閱讀框57抗體
xy-9821R C2orf292號(hào)染色體開(kāi)放閱讀框29抗體
xy-9826R C3orf213號(hào)染色體開(kāi)放閱讀框21抗體
xy-9792R C1ORF741號(hào)染色體開(kāi)放閱讀框74抗體
xy-9793R C1QTNF10補(bǔ)體C1q和腫瘤壞死因子相關(guān)蛋白10抗體
xy-9794R C1orf931號(hào)染色體開(kāi)放閱讀框93抗體
xy-9795R C1orf941號(hào)染色體開(kāi)放閱讀框94抗體
xy-9796R C1orf961號(hào)染色體開(kāi)放閱讀框96抗體
xy-9798R C1orf411號(hào)染色體開(kāi)放閱讀框41抗體
xy-9799R C1orf1441號(hào)染色體開(kāi)放閱讀框144抗體
xy-15191R C4orf34號(hào)染色體開(kāi)放閱讀框3抗體
xy-8558R Cathepsin S組織蛋白酶S抗體
xy-7605R Cell death inducing protein細(xì)胞死亡誘導(dǎo)蛋白抗體
xy-7603R Cipar1前列腺雄激素抑制信號(hào)蛋白1抗體
xy-9860R phospho-cardiac Troponin I (Thr143)磷酸化心肌肌鈣蛋白抗體
xy-11126R PVRL1脊髓灰質(zhì)炎受體相關(guān)蛋白1抗體
xy-13796R C19orf7319號(hào)染色體開(kāi)放閱讀框73抗體
xy-11127R CD11b整合素αM抗體Integrin αM
xy-11128R CASPR軸突蛋白4/少突膠質(zhì)細(xì)胞抗體
xy-11129R Caspr2軸突相關(guān)CNTP2蛋白抗體（少突膠質(zhì)細(xì)胞）
xy-7607R CSNK1D酪蛋白激酶δ1抗體
xy-1251R CD166活化白細(xì)胞粘附分子抗體
xy-15050R C1orf1911號(hào)染色體開(kāi)放閱讀框191抗體
xy-10066R Cox A16 polymerase3D柯薩奇病毒A16型聚合酶3D